PolyPid (PYPD) Invested Capital (2022 - 2026)
PolyPid (PYPD) posted Invested Capital of $801000.0 for Q1 2026, down 18.93% sequentially from $988000.0 in Q4 2025, and down 87.67% YoY from $6.5 million in Q1 2025.
PolyPid (PYPD) Invested Capital (2022 - 2026) Analysis & Trends
PolyPid has reported Invested Capital for 5 years, with the latest figure at $801000.0 in Q1 2026.
- Quarterly Invested Capital fell 87.67% year-over-year to $801000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.8 million (down 55.01% YoY) and the FY2025 annual result came in at $988000.0, down 85.44% from the prior year.
- Invested Capital retreated to $801000.0 in Q1 2026 per PYPD's latest filing, from $988000.0 in the prior quarter.
- Over five years, Invested Capital peaked at $6.8 million in Q4 2024 and troughed at $801000.0 in Q1 2026.
- A 5-year average of $3.8 million and a median of $4.0 million in 2022 frame the typical range for Invested Capital.
- The sharpest annual moves came in 2024 and 2026: Invested Capital surged 162.91% in 2024, then slumped 87.67% in 2026.
- Over 5 years, Invested Capital stood at $4.0 million in 2022, then decreased by 0.52% to $4.0 million in 2023, then surged by 69.55% to $6.8 million in 2024, then plunged by 85.44% to $988000.0 in 2025, then retreated by 18.93% to $801000.0 in 2026.
- According to Business Quant data, Invested Capital over the past three periods registered $801000.0, $988000.0, and $2.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 190.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.45 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 380.00 Mn |
| 10 | PolyPid | 113.86 Mn | 107.09 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 801,000.00 |
| Dec 31, 2025 | 988,000.00 |
| Sep 30, 2025 | 2.42 Mn |
| Jun 30, 2025 | 6.55 Mn |
| Mar 31, 2025 | 6.50 Mn |
| Dec 31, 2024 | 6.79 Mn |
| Sep 30, 2024 | 5.18 Mn |
| Jun 30, 2024 | 5.44 Mn |
| Mar 31, 2024 | 4.44 Mn |
| Dec 31, 2023 | 4.00 Mn |
| Sep 30, 2023 | 2.86 Mn |
| Jun 30, 2023 | 2.07 Mn |
| Mar 31, 2023 | 4.21 Mn |
| Dec 31, 2022 | 4.02 Mn |
| Sep 30, 2022 | 3.13 Mn |
| Jun 30, 2022 | 2.17 Mn |